New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands
Authors:
- Verónica NoeVNVerónica Noe
- Carles CiudadCarles Ciudad
- Maria J. PrietoMPMaria J. Prieto
- Mercè Font-BardiaMFMercè Font-Bardia
- Teresa CalvetTCTeresa Calvet
- Virtudes MorenoVMVirtudes Moreno
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 109, 72-81
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug DesignEuropean Journal of Inorganic Chemistry, 2009
- New trends for metal complexes with anticancer activityCurrent Opinion in Chemical Biology, 2008
- From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)Journal of Inorganic Biochemistry, 2006
- The Discovery and Development of CisplatinJournal of Chemical Education, 2006
- Development of organometallic (organo-transition metal) pharmaceuticalsApplied Organometallic Chemistry, 2005
- A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer AgentClinical Cancer Research, 2004
- Recent Developments in the Field of Tumor-Inhibiting Metal ComplexesCurrent Pharmaceutical Design, 2003
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug ResistanceChemical Reviews, 2003
- Current Status of Platinum-Based Antitumor DrugsChemical Reviews, 1999